moxifloxacin hydrochloride
moxifloxacin hydrochloride is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including MOXIFLOXACIN HYDROCHLORIDE, Moxifloxacin, VIGAMOX. Available dosage forms: tablet, film coated, powder, solution/ drops.
Drug Details
- Generic Name
- moxifloxacin hydrochloride
- Brand Names
- MOXIFLOXACIN HYDROCHLORIDE, Moxifloxacin, VIGAMOX, Moxifloxacin Ophthalmic Solution
- Application Number
- ANDA202632
- Sponsor
- PD-Rx Pharmaceuticals, Inc.
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, POWDER, SOLUTION/ DROPS
- Routes
- ORAL, OPHTHALMIC
- Active Ingredients
- MOXIFLOXACIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* , Micrococcus luteus*, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri*, Streptococcus pneumoniae, Streptococcus viridans group , Acinetobacter lwoffii*, Haemophilus influenzae, Haemophilus parainfluenzae*, Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. ( 1 )